The design of drugs for HIV and HCV

@article{Clercq2007TheDO,
  title={The design of drugs for HIV and HCV},
  author={E. Clercq},
  journal={Nature Reviews Drug Discovery},
  year={2007},
  volume={6},
  pages={1001-1018}
}
  • E. Clercq
  • Published 2007
  • Medicine
  • Nature Reviews Drug Discovery
Since the discovery of the human immunodeficiency virus (HIV) in 1983, dramatic progress has been made in the development of novel antiviral drugs. The HIV epidemic fuelled the development of new antiviral drug classes, which are now combined to provide highly active antiretroviral therapies. The need for the treatment of hepatitis C virus (HCV), which was discovered in 1989, has also provided considerable impetus for the development of new classes of antiviral drugs, and future treatment… Expand
Antiviral agents: structural basis of action and rational design.
Approaches for the development of antiviral compounds: the case of hepatitis C virus.
Emerging drugs for hepatitis C
Inhibition of HIV-1 replication by RNA-based strategies.
Antivirals: current state of the art
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 253 REFERENCES
Strategies in the design of antiviral drugs
  • E. Clercq
  • Biology
  • Nature Reviews Drug Discovery
  • 2002
Strategies in the design of antiviral drugs
An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus
Hepatitis C therapeutics: current status and emerging strategies
Antiviral agents active against influenza A viruses
...
1
2
3
4
5
...